Skip to main content
Top
Published in: Urolithiasis 2/2012

01-04-2012 | Review

Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?

Published in: Urolithiasis | Issue 2/2012

Login to get access

Abstract

Epidemiological studies have provided the evidence for association between nephrolithiasis and a number of cardiovascular diseases including hypertension, diabetes, chronic kidney disease, metabolic syndrome. Many of the co-morbidities may not only lead to stone disease but also be triggered by it. Nephrolithiasis is a risk factor for development of hypertension and have higher prevalence of diabetes mellitus and some hypertensive and diabetic patients are at greater risk for stone formation. An analysis of the association between stone disease and other simultaneously appearing disorders, as well as factors involved in their pathogenesis, may provide an insight into stone formation and improved therapies for stone recurrence and prevention. It is our hypothesis that association between stone formation and development of co-morbidities is a result of certain common pathological features. Review of the recent literature indicates that production of reactive oxygen species (ROS) and development of oxidative stress (OS) may be such a common pathway. OS is a common feature of all cardiovascular diseases (CVD) including hypertension, diabetes mellitus, atherosclerosis and myocardial infarct. There is increasing evidence that ROS are also produced during idiopathic calcium oxalate (CaOx) nephrolithiasis. Both tissue culture and animal model studies demonstrate that ROS are produced during interaction between CaOx/calcium phosphate (CaP) crystals and renal epithelial cells. Clinical studies have also provided evidence for the development of oxidative stress in the kidneys of stone forming patients. Renal disorders which lead to OS appear to be a continuum. Stress produced by one disorder may trigger the other under the right circumstances.
Literature
1.
go back to reference Pearle MS, Calhoun EA, Curhan GC (2005) Urologic diseases in America project: urolithiasis. J Urol 173:848PubMedCrossRef Pearle MS, Calhoun EA, Curhan GC (2005) Urologic diseases in America project: urolithiasis. J Urol 173:848PubMedCrossRef
2.
go back to reference Stamatelou KK, Francis ME, Jones CA et al (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817PubMedCrossRef Stamatelou KK, Francis ME, Jones CA et al (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817PubMedCrossRef
3.
go back to reference Soucie JM, Coates RJ, McClellan W et al (1996) Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epidemiol 143:487PubMed Soucie JM, Coates RJ, McClellan W et al (1996) Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epidemiol 143:487PubMed
4.
go back to reference Brikowski TH, Lotan Y, Pearle MS (2008) Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci USA 105:9841PubMedCrossRef Brikowski TH, Lotan Y, Pearle MS (2008) Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci USA 105:9841PubMedCrossRef
5.
go back to reference Obligado SH, Goldfarb DS (2008) The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens 21:257PubMedCrossRef Obligado SH, Goldfarb DS (2008) The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens 21:257PubMedCrossRef
6.
go back to reference Lieske JC, de la Vega LS, Gettman MT et al (2006) Diabetes mellitus and the risk of urinary tract stones: a population-based case–control study. Am J Kidney Dis 48:897PubMedCrossRef Lieske JC, de la Vega LS, Gettman MT et al (2006) Diabetes mellitus and the risk of urinary tract stones: a population-based case–control study. Am J Kidney Dis 48:897PubMedCrossRef
7.
go back to reference Jeong IG, Kang T, Bang JK et al (2011) Association between metabolic syndrome and the presence of kidney stones in a screened population. Am J Kidney Dis 58:383PubMedCrossRef Jeong IG, Kang T, Bang JK et al (2011) Association between metabolic syndrome and the presence of kidney stones in a screened population. Am J Kidney Dis 58:383PubMedCrossRef
8.
go back to reference Saucier NA, Sinha MK, Liang KV et al (2009) Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota. Am J Kidney Dis 55:61PubMedCrossRef Saucier NA, Sinha MK, Liang KV et al (2009) Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota. Am J Kidney Dis 55:61PubMedCrossRef
9.
go back to reference Coe FL, Evan AP, Worcester EM et al (2010) Three pathways for human kidney stone formation. Urol Res 38:147PubMedCrossRef Coe FL, Evan AP, Worcester EM et al (2010) Three pathways for human kidney stone formation. Urol Res 38:147PubMedCrossRef
10.
go back to reference Johri N, Cooper B, Robertson W et al (2010) An update and practical guide to renal stone management. Nephron Clin Pract 116:c159PubMedCrossRef Johri N, Cooper B, Robertson W et al (2010) An update and practical guide to renal stone management. Nephron Clin Pract 116:c159PubMedCrossRef
11.
go back to reference Tibblin G (1965) A population study of 50-year-old men. An analysis of the non-participation group. Acta Med Scand 178:453PubMedCrossRef Tibblin G (1965) A population study of 50-year-old men. An analysis of the non-participation group. Acta Med Scand 178:453PubMedCrossRef
12.
go back to reference Cirillo M, Laurenzi M (1988) Elevated blood pressure and positive history of kidney stones: results from a population-based study. J Hypertens Suppl 6:S485PubMed Cirillo M, Laurenzi M (1988) Elevated blood pressure and positive history of kidney stones: results from a population-based study. J Hypertens Suppl 6:S485PubMed
13.
go back to reference Cappuccio FP, Strazzullo P, Mancini M (1990) Kidney stones and hypertension: population based study of an independent clinical association. BMJ 300:1234PubMedCrossRef Cappuccio FP, Strazzullo P, Mancini M (1990) Kidney stones and hypertension: population based study of an independent clinical association. BMJ 300:1234PubMedCrossRef
14.
go back to reference Kim YJ, Park MS, Kim WT et al (2010) Hypertension influences recurrent stone formation in nonobese stone formers. Urology 77:1059PubMedCrossRef Kim YJ, Park MS, Kim WT et al (2010) Hypertension influences recurrent stone formation in nonobese stone formers. Urology 77:1059PubMedCrossRef
15.
go back to reference Cappuccio FP, Siani A, Barba G et al (1999) A prospective study of hypertension and the incidence of kidney stones in men. J Hypertens 17:1017PubMedCrossRef Cappuccio FP, Siani A, Barba G et al (1999) A prospective study of hypertension and the incidence of kidney stones in men. J Hypertens 17:1017PubMedCrossRef
16.
go back to reference Strazzullo P, Barba G, Vuotto P et al (2001) Past history of nephrolithiasis and incidence of hypertension in men: a reappraisal based on the results of the Olivetti Prospective Heart Study. Nephrol Dial Transplant 16:2232PubMedCrossRef Strazzullo P, Barba G, Vuotto P et al (2001) Past history of nephrolithiasis and incidence of hypertension in men: a reappraisal based on the results of the Olivetti Prospective Heart Study. Nephrol Dial Transplant 16:2232PubMedCrossRef
17.
go back to reference Madore F, Stampfer MJ, Rimm EB et al (1998) Nephrolithiasis and risk of hypertension. Am J Hypertens 11:46PubMedCrossRef Madore F, Stampfer MJ, Rimm EB et al (1998) Nephrolithiasis and risk of hypertension. Am J Hypertens 11:46PubMedCrossRef
18.
go back to reference Madore F, Stampfer MJ, Willett WC et al (1998) Nephrolithiasis and risk of hypertension in women. Am J Kidney Dis 32:802PubMedCrossRef Madore F, Stampfer MJ, Willett WC et al (1998) Nephrolithiasis and risk of hypertension in women. Am J Kidney Dis 32:802PubMedCrossRef
19.
go back to reference Borghi L, Meschi T, Guerra A et al (1999) Essential arterial hypertension and stone disease. Kidney Int 55:2397PubMedCrossRef Borghi L, Meschi T, Guerra A et al (1999) Essential arterial hypertension and stone disease. Kidney Int 55:2397PubMedCrossRef
20.
go back to reference Stoller ML, Low RK, Shami GS et al (1996) High resolution radiography of cadaveric kidneys: unraveling the mystery of Randall’s plaque formation. J Urol 156:1263PubMedCrossRef Stoller ML, Low RK, Shami GS et al (1996) High resolution radiography of cadaveric kidneys: unraveling the mystery of Randall’s plaque formation. J Urol 156:1263PubMedCrossRef
21.
go back to reference Wexler BC, McMurtry JP (1981) Kidney and bladder calculi in spontaneously hypertensive rats. Br J Exp Pathol 62:369PubMed Wexler BC, McMurtry JP (1981) Kidney and bladder calculi in spontaneously hypertensive rats. Br J Exp Pathol 62:369PubMed
22.
go back to reference Koletsky S (1975) Pathologic findings and laboratory data in a new strain of obese hypertensive rats. Am J Pathol 80:129PubMed Koletsky S (1975) Pathologic findings and laboratory data in a new strain of obese hypertensive rats. Am J Pathol 80:129PubMed
23.
go back to reference Domingos F, Serra A (2010) Nephrolithiasis is associated with an increased prevalence of cardiovascular disease. Nephrol Dial Transplant 26:864PubMedCrossRef Domingos F, Serra A (2010) Nephrolithiasis is associated with an increased prevalence of cardiovascular disease. Nephrol Dial Transplant 26:864PubMedCrossRef
24.
go back to reference Akoudad S, Szklo M, McAdams MA et al (2010) Correlates of kidney stone disease differ by race in a multi-ethnic middle-aged population: the ARIC study. Prev Med 51:416PubMedCrossRef Akoudad S, Szklo M, McAdams MA et al (2010) Correlates of kidney stone disease differ by race in a multi-ethnic middle-aged population: the ARIC study. Prev Med 51:416PubMedCrossRef
25.
go back to reference Gillen DL, Coe FL, Worcester EM (2005) Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis 46:263PubMedCrossRef Gillen DL, Coe FL, Worcester EM (2005) Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis 46:263PubMedCrossRef
26.
go back to reference Breslau NA, Pak CY (1982) Endocrine aspects of nephrolithiasis. Spec Top Endocrinol Metab 3:57PubMed Breslau NA, Pak CY (1982) Endocrine aspects of nephrolithiasis. Spec Top Endocrinol Metab 3:57PubMed
27.
go back to reference Liu JG, Hu M, He XQ (1989) Risk factors for the formation of urinary calcium-containing stones in diabetics. Zhonghua Nei Ke Za Zhi 28:649PubMed Liu JG, Hu M, He XQ (1989) Risk factors for the formation of urinary calcium-containing stones in diabetics. Zhonghua Nei Ke Za Zhi 28:649PubMed
28.
go back to reference Meydan N, Barutca S, Caliskan S et al (2003) Urinary stone disease in diabetes mellitus. Scand J Urol Nephrol 37:64PubMedCrossRef Meydan N, Barutca S, Caliskan S et al (2003) Urinary stone disease in diabetes mellitus. Scand J Urol Nephrol 37:64PubMedCrossRef
29.
go back to reference Taylor EN, Stampfer MJ, Curhan GC (2005) Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 68:1230PubMedCrossRef Taylor EN, Stampfer MJ, Curhan GC (2005) Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 68:1230PubMedCrossRef
30.
go back to reference Pak CY, Sakhaee K, Moe O et al (2003) Biochemical profile of stone-forming patients with diabetes mellitus. Urology 61:523PubMedCrossRef Pak CY, Sakhaee K, Moe O et al (2003) Biochemical profile of stone-forming patients with diabetes mellitus. Urology 61:523PubMedCrossRef
31.
go back to reference Daudon M, Traxer O, Conort P et al (2006) Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 17:2026PubMedCrossRef Daudon M, Traxer O, Conort P et al (2006) Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 17:2026PubMedCrossRef
32.
go back to reference Zimmerer T, Weiss C, Hammes HP et al (2009) Evaluation of urolithiasis: a link between stone formation and diabetes mellitus? Urol Int 82:350PubMedCrossRef Zimmerer T, Weiss C, Hammes HP et al (2009) Evaluation of urolithiasis: a link between stone formation and diabetes mellitus? Urol Int 82:350PubMedCrossRef
33.
go back to reference Eisner BH, Porten SP, Bechis SK et al (2010) Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol 183:2244PubMedCrossRef Eisner BH, Porten SP, Bechis SK et al (2010) Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol 183:2244PubMedCrossRef
34.
go back to reference Hamano S, Nakatsu H, Suzuki N et al (2005) Kidney stone disease and risk factors for coronary heart disease. Int J Urol 12:859PubMedCrossRef Hamano S, Nakatsu H, Suzuki N et al (2005) Kidney stone disease and risk factors for coronary heart disease. Int J Urol 12:859PubMedCrossRef
35.
36.
go back to reference Rule AD, Bergstralh EJ, Melton LJ 3rd et al (2009) Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4:804PubMedCrossRef Rule AD, Bergstralh EJ, Melton LJ 3rd et al (2009) Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4:804PubMedCrossRef
37.
go back to reference Rule AD, Roger VL, Melton LJ 3rd et al (2010) Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol 21:1641PubMedCrossRef Rule AD, Roger VL, Melton LJ 3rd et al (2010) Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol 21:1641PubMedCrossRef
38.
go back to reference Reiner AP, Kahn A, Eisner BH et al (2011) Kidney stones and subclinical atherosclerosis in young adults: the CARDIA study. J Urol 185:920PubMedCrossRef Reiner AP, Kahn A, Eisner BH et al (2011) Kidney stones and subclinical atherosclerosis in young adults: the CARDIA study. J Urol 185:920PubMedCrossRef
39.
go back to reference Gupta M, Bolton DM, Gupta PN et al (1994) Improved renal function following aggressive treatment of urolithiasis and concurrent mild to moderate renal insufficiency. J Urol 152:1086PubMed Gupta M, Bolton DM, Gupta PN et al (1994) Improved renal function following aggressive treatment of urolithiasis and concurrent mild to moderate renal insufficiency. J Urol 152:1086PubMed
40.
go back to reference Goel MC, Ahlawat R, Kumar M et al (1997) Chronic renal failure and nephrolithiasis in a solitary kidney: role of intervention. J Urol 157:1574PubMedCrossRef Goel MC, Ahlawat R, Kumar M et al (1997) Chronic renal failure and nephrolithiasis in a solitary kidney: role of intervention. J Urol 157:1574PubMedCrossRef
41.
go back to reference Gillen DL, Worcester EM, Coe FL (2005) Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int 67:685PubMedCrossRef Gillen DL, Worcester EM, Coe FL (2005) Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int 67:685PubMedCrossRef
42.
go back to reference Vupputuri S, Soucie JM, McClellan W et al (2004) History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol 14:222PubMedCrossRef Vupputuri S, Soucie JM, McClellan W et al (2004) History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol 14:222PubMedCrossRef
43.
go back to reference Ingsathit A, Thakkinstian A, Chaiprasert A et al (2010) Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant 25:1567PubMedCrossRef Ingsathit A, Thakkinstian A, Chaiprasert A et al (2010) Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant 25:1567PubMedCrossRef
44.
go back to reference Meneses JA, Lucas FM, Assuncao FC et al (2011) The impact of metaphylaxis of kidney stone disease in the renal function at long term in active kidney stone formers patients. Urol Res [Epub ahead of print] Meneses JA, Lucas FM, Assuncao FC et al (2011) The impact of metaphylaxis of kidney stone disease in the renal function at long term in active kidney stone formers patients. Urol Res [Epub ahead of print]
45.
go back to reference Dandona P, Aljada A, Chaudhuri A et al (2005) Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111:1448PubMedCrossRef Dandona P, Aljada A, Chaudhuri A et al (2005) Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111:1448PubMedCrossRef
46.
go back to reference Curhan GC, Willett WC, Rimm EB et al (1998) Body size and risk of kidney stones. J Am Soc Nephrol 9:1645PubMed Curhan GC, Willett WC, Rimm EB et al (1998) Body size and risk of kidney stones. J Am Soc Nephrol 9:1645PubMed
47.
go back to reference Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293:455PubMedCrossRef Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293:455PubMedCrossRef
48.
go back to reference West B, Luke A, Durazo-Arvizu RA et al (2008) Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am J Kidney Dis 51:741PubMedCrossRef West B, Luke A, Durazo-Arvizu RA et al (2008) Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am J Kidney Dis 51:741PubMedCrossRef
49.
go back to reference Ando R, Suzuki S, Nagaya T et al (2011) Impact of insulin resistance, insulin and adiponectin on kidney stones in the Japanese population. Int J Urol 18:131PubMedCrossRef Ando R, Suzuki S, Nagaya T et al (2011) Impact of insulin resistance, insulin and adiponectin on kidney stones in the Japanese population. Int J Urol 18:131PubMedCrossRef
50.
go back to reference Ferder L, Ferder MD, Inserra F (2010) The role of high-fructose corn syrup in metabolic syndrome and hypertension. Curr Hypertens Rep 12:105PubMedCrossRef Ferder L, Ferder MD, Inserra F (2010) The role of high-fructose corn syrup in metabolic syndrome and hypertension. Curr Hypertens Rep 12:105PubMedCrossRef
51.
go back to reference Jalal DI, Smits G, Johnson RJ et al (2010) Increased fructose associates with elevated blood pressure. J Am Soc Nephrol 21:1543PubMedCrossRef Jalal DI, Smits G, Johnson RJ et al (2010) Increased fructose associates with elevated blood pressure. J Am Soc Nephrol 21:1543PubMedCrossRef
52.
54.
go back to reference Kok DJ, Khan SR (1994) Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 46:847PubMedCrossRef Kok DJ, Khan SR (1994) Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 46:847PubMedCrossRef
56.
go back to reference Cameron MA, Maalouf NM, Adams-Huet B et al (2006) Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol 17:1422PubMedCrossRef Cameron MA, Maalouf NM, Adams-Huet B et al (2006) Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol 17:1422PubMedCrossRef
57.
go back to reference Strazzullo P, Mancini M (1994) Hypertension, calcium metabolism, and nephrolithiasis. Am J Med Sci 307(Suppl 1):S102PubMed Strazzullo P, Mancini M (1994) Hypertension, calcium metabolism, and nephrolithiasis. Am J Med Sci 307(Suppl 1):S102PubMed
58.
go back to reference Timio F, Kerry SM, Anson KM et al (2003) Calcium urolithiasis, blood pressure and salt intake. Blood Press 12:122PubMedCrossRef Timio F, Kerry SM, Anson KM et al (2003) Calcium urolithiasis, blood pressure and salt intake. Blood Press 12:122PubMedCrossRef
59.
60.
go back to reference Mente A, Honey RJ, McLaughlin JM et al (2006) High urinary calcium excretion and genetic susceptibility to hypertension and kidney stone disease. J Am Soc Nephrol 17:2567PubMedCrossRef Mente A, Honey RJ, McLaughlin JM et al (2006) High urinary calcium excretion and genetic susceptibility to hypertension and kidney stone disease. J Am Soc Nephrol 17:2567PubMedCrossRef
61.
go back to reference Schleicher MM, Reis MC, Costa SS et al (2009) Patients with nephrolithiasis and blood hypertension have higher calciuria than those with isolated nephrolithiasis or hypertension? Minerva Urol Nefrol 61:9PubMed Schleicher MM, Reis MC, Costa SS et al (2009) Patients with nephrolithiasis and blood hypertension have higher calciuria than those with isolated nephrolithiasis or hypertension? Minerva Urol Nefrol 61:9PubMed
62.
go back to reference Eisner BH, Porten SP, Bechis SK et al (2010) Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis. J Urol 183:576PubMedCrossRef Eisner BH, Porten SP, Bechis SK et al (2010) Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis. J Urol 183:576PubMedCrossRef
63.
go back to reference Taylor EN, Mount DB, Forman JP et al (2006) Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors. Am J Kidney Dis 47:780PubMedCrossRef Taylor EN, Mount DB, Forman JP et al (2006) Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors. Am J Kidney Dis 47:780PubMedCrossRef
64.
go back to reference Maalouf NM, Cameron MA, Moe OW et al (2010) Metabolic basis for low urine pH in type 2 diabetes. Clin J Am Soc Nephrol 5:1277PubMedCrossRef Maalouf NM, Cameron MA, Moe OW et al (2010) Metabolic basis for low urine pH in type 2 diabetes. Clin J Am Soc Nephrol 5:1277PubMedCrossRef
66.
go back to reference Carpentier X, Bazin D, Jungers P et al (2010) The pathogenesis of Randall’s plaque: a papilla cartography of Ca compounds through an ex vivo investigation based on XANES spectroscopy. J Synchrotron Radiat 17:374PubMedCrossRef Carpentier X, Bazin D, Jungers P et al (2010) The pathogenesis of Randall’s plaque: a papilla cartography of Ca compounds through an ex vivo investigation based on XANES spectroscopy. J Synchrotron Radiat 17:374PubMedCrossRef
67.
go back to reference Khan SR, Finlayson B, Hackett R (1984) Renal papillary changes in patient with calcium oxalate lithiasis. Urology 23:194PubMedCrossRef Khan SR, Finlayson B, Hackett R (1984) Renal papillary changes in patient with calcium oxalate lithiasis. Urology 23:194PubMedCrossRef
68.
go back to reference Evan AP, Lingeman JE, Coe FL et al (2003) Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607PubMed Evan AP, Lingeman JE, Coe FL et al (2003) Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607PubMed
69.
go back to reference Weller RO, Nester B, Cooke SAR (1971) Calcification in the human renal papilla: an electron microscope study. J Pathol 107:211CrossRef Weller RO, Nester B, Cooke SAR (1971) Calcification in the human renal papilla: an electron microscope study. J Pathol 107:211CrossRef
70.
go back to reference Stoller ML, Meng MV, Abrahams HM et al (2004) The primary stone event: a new hypothesis involving a vascular etiology. J Urol 171:1920PubMedCrossRef Stoller ML, Meng MV, Abrahams HM et al (2004) The primary stone event: a new hypothesis involving a vascular etiology. J Urol 171:1920PubMedCrossRef
71.
go back to reference Miller NL, Gillen DL, Williams JC Jr et al (2009) A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall’s plaque. BJU Int 103:966PubMedCrossRef Miller NL, Gillen DL, Williams JC Jr et al (2009) A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall’s plaque. BJU Int 103:966PubMedCrossRef
72.
go back to reference Coe FL, Evan AP, Lingeman JE et al (2010) Plaque and deposits in nine human stone diseases. Urol Res 38:239PubMedCrossRef Coe FL, Evan AP, Lingeman JE et al (2010) Plaque and deposits in nine human stone diseases. Urol Res 38:239PubMedCrossRef
73.
go back to reference Evan AP, Lingeman JE, Coe FL et al (2008) Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol 28:111PubMedCrossRef Evan AP, Lingeman JE, Coe FL et al (2008) Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol 28:111PubMedCrossRef
74.
go back to reference Evan AP (2009) Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol 25:831PubMedCrossRef Evan AP (2009) Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol 25:831PubMedCrossRef
75.
go back to reference Evan AP, Coe FL, Rittling SR et al (2005) Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int 68:145PubMedCrossRef Evan AP, Coe FL, Rittling SR et al (2005) Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int 68:145PubMedCrossRef
76.
go back to reference Evan AP, Bledsoe S, Worcester EM et al (2007) Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients. Kidney Int 72:1503PubMedCrossRef Evan AP, Bledsoe S, Worcester EM et al (2007) Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients. Kidney Int 72:1503PubMedCrossRef
77.
go back to reference Evan A, Lingeman J, Coe FL et al (2006) Randall’s plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int 69:1313PubMedCrossRef Evan A, Lingeman J, Coe FL et al (2006) Randall’s plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int 69:1313PubMedCrossRef
78.
go back to reference Haggit RC, Pitcock JA (1971) Renal medullary calcification: a light and electron microscopic study. J Urol 106:342 Haggit RC, Pitcock JA (1971) Renal medullary calcification: a light and electron microscopic study. J Urol 106:342
79.
80.
go back to reference Carpentier X, Bazin D, Combes C et al (2011) High Zn content of Randall’s plaque: a mu-X-ray fluorescence investigation. J Trace Elem Med Biol 25:160PubMedCrossRef Carpentier X, Bazin D, Combes C et al (2011) High Zn content of Randall’s plaque: a mu-X-ray fluorescence investigation. J Trace Elem Med Biol 25:160PubMedCrossRef
81.
go back to reference Khan SR (2004) Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol 8:75PubMedCrossRef Khan SR (2004) Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol 8:75PubMedCrossRef
82.
go back to reference Gower LB (2008) Biomimetic model systems for investigating the amorphous precursor pathway and its role in biomineralization. Chem Rev 108:4551PubMedCrossRef Gower LB (2008) Biomimetic model systems for investigating the amorphous precursor pathway and its role in biomineralization. Chem Rev 108:4551PubMedCrossRef
83.
go back to reference Murshed M, McKee MD (2010) Molecular determinants of extracellular matrix mineralization in bone and blood vessels. Curr Opin Nephrol Hypertens 19:359PubMedCrossRef Murshed M, McKee MD (2010) Molecular determinants of extracellular matrix mineralization in bone and blood vessels. Curr Opin Nephrol Hypertens 19:359PubMedCrossRef
84.
go back to reference Baggio B, Gambaro G, Ossi E et al (1983) Increased urinary excretion of renal enzymes in idiopathic calcium oxalate nephrolithiasis. J Urol 129:1161PubMed Baggio B, Gambaro G, Ossi E et al (1983) Increased urinary excretion of renal enzymes in idiopathic calcium oxalate nephrolithiasis. J Urol 129:1161PubMed
85.
go back to reference Huang HS, Ma MC, Chen CF et al (2003) Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones. Urology 62:1123PubMedCrossRef Huang HS, Ma MC, Chen CF et al (2003) Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones. Urology 62:1123PubMedCrossRef
86.
go back to reference Tungsanga K, Sriboonlue P, Futrakul P et al (2005) Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment. Urol Res 33:65PubMedCrossRef Tungsanga K, Sriboonlue P, Futrakul P et al (2005) Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment. Urol Res 33:65PubMedCrossRef
87.
go back to reference Boonla C, Wunsuwan R, Tungsanga K et al (2007) Urinary 8-hydroxydeoxyguanosine is elevated in patients with nephrolithiasis. Urol Res 35:185PubMedCrossRef Boonla C, Wunsuwan R, Tungsanga K et al (2007) Urinary 8-hydroxydeoxyguanosine is elevated in patients with nephrolithiasis. Urol Res 35:185PubMedCrossRef
88.
go back to reference Tsao KC, Wu TL, Chang PY et al (2007) Multiple risk markers for atherogenesis associated with chronic inflammation are detectable in patients with renal stones. J Clin Lab Anal 21:426PubMedCrossRef Tsao KC, Wu TL, Chang PY et al (2007) Multiple risk markers for atherogenesis associated with chronic inflammation are detectable in patients with renal stones. J Clin Lab Anal 21:426PubMedCrossRef
89.
go back to reference Mushtaq S, Siddiqui AA, Naqvi ZA et al (2007) Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones. Clin Chim Acta 384:41PubMedCrossRef Mushtaq S, Siddiqui AA, Naqvi ZA et al (2007) Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones. Clin Chim Acta 384:41PubMedCrossRef
90.
go back to reference Taylor EN, Fung TT, Curhan GC (2009) DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol 20:2253PubMedCrossRef Taylor EN, Fung TT, Curhan GC (2009) DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol 20:2253PubMedCrossRef
91.
go back to reference Evan AP, Coe FL, Lingeman JE et al (2006) Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int 69:2227PubMedCrossRef Evan AP, Coe FL, Lingeman JE et al (2006) Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int 69:2227PubMedCrossRef
92.
go back to reference Evan AP, Lingeman J, Coe F et al (2007) Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int 71:795PubMedCrossRef Evan AP, Lingeman J, Coe F et al (2007) Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int 71:795PubMedCrossRef
93.
go back to reference Evan AP, Lingeman JE, Coe FL et al (2005) Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 67:576PubMedCrossRef Evan AP, Lingeman JE, Coe FL et al (2005) Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 67:576PubMedCrossRef
94.
go back to reference Evan AP, Lingeman JE, Worcester EM et al (2010) Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease. Kidney Int 78:310PubMedCrossRef Evan AP, Lingeman JE, Worcester EM et al (2010) Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease. Kidney Int 78:310PubMedCrossRef
95.
go back to reference Evan AP, Coe FL, Gillen D et al (2008) Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec (Hoboken) 291:325CrossRef Evan AP, Coe FL, Gillen D et al (2008) Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec (Hoboken) 291:325CrossRef
96.
go back to reference Evan AE, Lingeman JE, Coe FL et al (2008) Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Int 74:223PubMedCrossRef Evan AE, Lingeman JE, Coe FL et al (2008) Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Int 74:223PubMedCrossRef
97.
go back to reference Escobar C, Byer KJ, Khaskheli H et al (2008) Apatite induced renal epithelial injury: insight into the pathogenesis of kidney stones. J Urol 180:379PubMedCrossRef Escobar C, Byer KJ, Khaskheli H et al (2008) Apatite induced renal epithelial injury: insight into the pathogenesis of kidney stones. J Urol 180:379PubMedCrossRef
98.
go back to reference Aihara K, Byer KJ, Khan SR (2003) Calcium phosphate-induced renal epithelial injury and stone formation: involvement of reactive oxygen species. Kidney Int 64:1283PubMedCrossRef Aihara K, Byer KJ, Khan SR (2003) Calcium phosphate-induced renal epithelial injury and stone formation: involvement of reactive oxygen species. Kidney Int 64:1283PubMedCrossRef
99.
go back to reference Umekawa T, Byer K, Uemura H et al (2005) Diphenyleneiodium (DPI) reduces oxalate ion- and calcium oxalate monohydrate and brushite crystal-induced upregulation of MCP-1 in NRK 52E cells. Nephrol Dial Transplant 20:870PubMedCrossRef Umekawa T, Byer K, Uemura H et al (2005) Diphenyleneiodium (DPI) reduces oxalate ion- and calcium oxalate monohydrate and brushite crystal-induced upregulation of MCP-1 in NRK 52E cells. Nephrol Dial Transplant 20:870PubMedCrossRef
100.
go back to reference Umekawa T, Chegini N, Khan SR (2003) Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant 18:664PubMedCrossRef Umekawa T, Chegini N, Khan SR (2003) Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant 18:664PubMedCrossRef
101.
go back to reference Giachelli CM (2005) Inducers and inhibitors of biomineralization: lessons from pathological calcification. Orthod Craniofac Res 8:229PubMedCrossRef Giachelli CM (2005) Inducers and inhibitors of biomineralization: lessons from pathological calcification. Orthod Craniofac Res 8:229PubMedCrossRef
102.
go back to reference Thamilselvan S, Hackett RL, Khan SR (1997) Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J Urol 157:1059PubMedCrossRef Thamilselvan S, Hackett RL, Khan SR (1997) Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J Urol 157:1059PubMedCrossRef
103.
go back to reference Thamilselvan S, Hackett RL, Khan SR (1999) Cells of proximal and distal tubular origin respond differently to challenges of oxalate and calcium oxalate crystals. J Am Soc Nephrol 10(Suppl 14):S452PubMed Thamilselvan S, Hackett RL, Khan SR (1999) Cells of proximal and distal tubular origin respond differently to challenges of oxalate and calcium oxalate crystals. J Am Soc Nephrol 10(Suppl 14):S452PubMed
104.
go back to reference Khan SR (2005) Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res 33:349PubMedCrossRef Khan SR (2005) Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res 33:349PubMedCrossRef
105.
go back to reference Khan SR, Glenton PA, Byer KJ (2006) Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-l-proline. Kidney Int 70:914PubMedCrossRef Khan SR, Glenton PA, Byer KJ (2006) Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-l-proline. Kidney Int 70:914PubMedCrossRef
106.
go back to reference Khan SR (1995) Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development. Urol Res 23:71PubMedCrossRef Khan SR (1995) Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development. Urol Res 23:71PubMedCrossRef
107.
go back to reference Sumitra K, Pragasam V, Sakthivel R et al (2005) Beneficial effect of vitamin E supplementation on the biochemical and kinetic properties of Tamm–Horsfall glycoprotein in hypertensive and hyperoxaluric patients. Nephrol Dial Transplant 20:1407PubMedCrossRef Sumitra K, Pragasam V, Sakthivel R et al (2005) Beneficial effect of vitamin E supplementation on the biochemical and kinetic properties of Tamm–Horsfall glycoprotein in hypertensive and hyperoxaluric patients. Nephrol Dial Transplant 20:1407PubMedCrossRef
108.
go back to reference Huang HS, Chen J, Chen CF et al (2006) Vitamin E attenuates crystal formation in rat kidneys: roles of renal tubular cell death and crystallization inhibitors. Kidney Int 70:699PubMedCrossRef Huang HS, Chen J, Chen CF et al (2006) Vitamin E attenuates crystal formation in rat kidneys: roles of renal tubular cell death and crystallization inhibitors. Kidney Int 70:699PubMedCrossRef
109.
go back to reference Thamilselvan S, Byer KJ, Hackett RL et al (2000) Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells. J Urol 164:224PubMedCrossRef Thamilselvan S, Byer KJ, Hackett RL et al (2000) Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells. J Urol 164:224PubMedCrossRef
110.
go back to reference Thamilselvan S, Khan SR, Menon M (2003) Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 31:3PubMed Thamilselvan S, Khan SR, Menon M (2003) Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 31:3PubMed
111.
go back to reference Khand FD, Gordge MP, Robertson WG et al (2002) Mitochondrial superoxide production during oxalate-mediated oxidative stress in renal epithelial cells. Free Radic Biol Med 32:1339PubMedCrossRef Khand FD, Gordge MP, Robertson WG et al (2002) Mitochondrial superoxide production during oxalate-mediated oxidative stress in renal epithelial cells. Free Radic Biol Med 32:1339PubMedCrossRef
112.
go back to reference Meimaridou E, Jacobson J, Seddon AM et al (2005) Crystal and microparticle effects on MDCK cell superoxide production: oxalate-specific mitochondrial membrane potential changes. Free Radic Biol Med 38:1553PubMedCrossRef Meimaridou E, Jacobson J, Seddon AM et al (2005) Crystal and microparticle effects on MDCK cell superoxide production: oxalate-specific mitochondrial membrane potential changes. Free Radic Biol Med 38:1553PubMedCrossRef
113.
go back to reference Cao LC, Honeyman TW, Cooney R et al (2004) Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity. Kidney Int 66:1890PubMedCrossRef Cao LC, Honeyman TW, Cooney R et al (2004) Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity. Kidney Int 66:1890PubMedCrossRef
114.
go back to reference Khan SR, Khan A, Byer KJ (2011) Temporal changes in the expression of mRNA of NADPH oxidase subunits in renal epithelial cells exposed to oxalate or calcium oxalate crystals. Nephrol Dial Transplant 26:1778PubMedCrossRef Khan SR, Khan A, Byer KJ (2011) Temporal changes in the expression of mRNA of NADPH oxidase subunits in renal epithelial cells exposed to oxalate or calcium oxalate crystals. Nephrol Dial Transplant 26:1778PubMedCrossRef
115.
go back to reference Li N, Yi FX, Spurrier JL et al (2002) Production of superoxide through NADH oxidase in thick ascending limb of Henle’s loop in rat kidney. Am J Physiol Renal Physiol 282:F1111PubMed Li N, Yi FX, Spurrier JL et al (2002) Production of superoxide through NADH oxidase in thick ascending limb of Henle’s loop in rat kidney. Am J Physiol Renal Physiol 282:F1111PubMed
116.
go back to reference Geiszt M, Kopp JB, Varnai P et al (2000) Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA 97:8010PubMedCrossRef Geiszt M, Kopp JB, Varnai P et al (2000) Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA 97:8010PubMedCrossRef
117.
go back to reference Hanna IR, Taniyama Y, Szocs K et al (2002) NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 4:899PubMedCrossRef Hanna IR, Taniyama Y, Szocs K et al (2002) NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 4:899PubMedCrossRef
118.
go back to reference Wilcox CS, Welch WJ (2001) Oxidative stress: cause or consequence of hypertension. Exp Biol Med (Maywood) 226:619 Wilcox CS, Welch WJ (2001) Oxidative stress: cause or consequence of hypertension. Exp Biol Med (Maywood) 226:619
119.
go back to reference Shiose A, Kuroda J, Tsuruya K et al (2001) A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem 276:1417PubMedCrossRef Shiose A, Kuroda J, Tsuruya K et al (2001) A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem 276:1417PubMedCrossRef
120.
go back to reference Thamilselvan V, Menon M, Thamilselvan S (2009) Oxalate-induced activation of PKC-alpha and -delta regulates NADPH oxidase-mediated oxidative injury in renal tubular epithelial cells. Am J Physiol Renal Physiol 297:F1399PubMedCrossRef Thamilselvan V, Menon M, Thamilselvan S (2009) Oxalate-induced activation of PKC-alpha and -delta regulates NADPH oxidase-mediated oxidative injury in renal tubular epithelial cells. Am J Physiol Renal Physiol 297:F1399PubMedCrossRef
121.
go back to reference Thamilselvan V, Menon M, Thamilselvan S (2011) Selective Rac1 inhibition protects renal tubular epithelial cells from oxalate-induced NADPH oxidase-mediated oxidative cell injury. Urol Res [Epub ahead of print] Thamilselvan V, Menon M, Thamilselvan S (2011) Selective Rac1 inhibition protects renal tubular epithelial cells from oxalate-induced NADPH oxidase-mediated oxidative cell injury. Urol Res [Epub ahead of print]
122.
go back to reference Zuo J, Khan A, Glenton PA et al (2011) Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-l-proline-induced hyperoxaluria in the male Sprague-Dawley rats. Nephrol Dial Transplant 26:1785PubMedCrossRef Zuo J, Khan A, Glenton PA et al (2011) Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-l-proline-induced hyperoxaluria in the male Sprague-Dawley rats. Nephrol Dial Transplant 26:1785PubMedCrossRef
123.
go back to reference Wassmann S, Laufs U, Muller K et al (2002) Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol 22:300PubMedCrossRef Wassmann S, Laufs U, Muller K et al (2002) Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol 22:300PubMedCrossRef
124.
go back to reference Tsujihata M, Momohara C, Yoshioka I et al (2008) Atorvastatin inhibits renal crystal retention in a rat stone forming model. J Urol 180:2212PubMedCrossRef Tsujihata M, Momohara C, Yoshioka I et al (2008) Atorvastatin inhibits renal crystal retention in a rat stone forming model. J Urol 180:2212PubMedCrossRef
125.
go back to reference Toblli JE, Ferder L, Stella I et al (2001) Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria. J Urol 166:275PubMedCrossRef Toblli JE, Ferder L, Stella I et al (2001) Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria. J Urol 166:275PubMedCrossRef
126.
go back to reference Toblli JE, Ferder L, Stella I et al (2002) Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria. J Urol 168:1550PubMedCrossRef Toblli JE, Ferder L, Stella I et al (2002) Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria. J Urol 168:1550PubMedCrossRef
127.
go back to reference Umekawa T, Hatanaka Y, Kurita T et al (2004) Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys. J Am Soc Nephrol 15:635PubMedCrossRef Umekawa T, Hatanaka Y, Kurita T et al (2004) Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys. J Am Soc Nephrol 15:635PubMedCrossRef
128.
go back to reference Khan SR, Shevock PN, Hackett RL (1992) Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis. J Urol 147:226PubMed Khan SR, Shevock PN, Hackett RL (1992) Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis. J Urol 147:226PubMed
129.
go back to reference de Bruijn WC, Boeve ER, van Run PR et al (1995) Etiology of calcium oxalate nephrolithiasis in rats. I. Can this be a model for human stone formation? Scanning Microsc 9:103PubMed de Bruijn WC, Boeve ER, van Run PR et al (1995) Etiology of calcium oxalate nephrolithiasis in rats. I. Can this be a model for human stone formation? Scanning Microsc 9:103PubMed
130.
go back to reference de Water R, Noordermeer C, van der Kwast TH et al (1999) Calcium oxalate nephrolithiasis: effect of renal crystal deposition on the cellular composition of the renal interstitium. Am J Kidney Dis 33:761PubMedCrossRef de Water R, Noordermeer C, van der Kwast TH et al (1999) Calcium oxalate nephrolithiasis: effect of renal crystal deposition on the cellular composition of the renal interstitium. Am J Kidney Dis 33:761PubMedCrossRef
131.
go back to reference McKee MD, Nanci A, Khan SR (1995) Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi. J Bone Miner Res 10:1913PubMedCrossRef McKee MD, Nanci A, Khan SR (1995) Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi. J Bone Miner Res 10:1913PubMedCrossRef
132.
go back to reference Umekawa T, Tsuji H, Uemura H et al (2009) Superoxide from NADPH oxidase as second messenger for the expression of osteopontin and monocyte chemoattractant protein-1 in renal epithelial cells exposed to calcium oxalate crystals. BJU Int 104:115PubMedCrossRef Umekawa T, Tsuji H, Uemura H et al (2009) Superoxide from NADPH oxidase as second messenger for the expression of osteopontin and monocyte chemoattractant protein-1 in renal epithelial cells exposed to calcium oxalate crystals. BJU Int 104:115PubMedCrossRef
133.
go back to reference Rashed T, Menon M, Thamilselvan S (2004) Molecular mechanism of oxalate-induced free radical production and glutathione redox imbalance in renal epithelial cells: effect of antioxidants. Am J Nephrol 24:557PubMedCrossRef Rashed T, Menon M, Thamilselvan S (2004) Molecular mechanism of oxalate-induced free radical production and glutathione redox imbalance in renal epithelial cells: effect of antioxidants. Am J Nephrol 24:557PubMedCrossRef
134.
go back to reference Koul HK, Menon M, Chaturvedi LS et al (2002) COM crystals activate the p38 mitogen-activated protein kinase signal transduction pathway in renal epithelial cells. J Biol Chem 277:36845PubMedCrossRef Koul HK, Menon M, Chaturvedi LS et al (2002) COM crystals activate the p38 mitogen-activated protein kinase signal transduction pathway in renal epithelial cells. J Biol Chem 277:36845PubMedCrossRef
135.
go back to reference Chaturvedi LS, Koul S, Sekhon A et al (2002) Oxalate selectively activates p38 mitogen-activated protein kinase and c-Jun N-terminal kinase signal transduction pathways in renal epithelial cells. J Biol Chem 277:13321PubMedCrossRef Chaturvedi LS, Koul S, Sekhon A et al (2002) Oxalate selectively activates p38 mitogen-activated protein kinase and c-Jun N-terminal kinase signal transduction pathways in renal epithelial cells. J Biol Chem 277:13321PubMedCrossRef
136.
go back to reference Toblli JE, Cao G, Casas G et al (2005) NF-kappaB and chemokine-cytokine expression in renal tubulointerstitium in experimental hyperoxaluria. Role of the renin–angiotensin system. Urol Res 33:358PubMedCrossRef Toblli JE, Cao G, Casas G et al (2005) NF-kappaB and chemokine-cytokine expression in renal tubulointerstitium in experimental hyperoxaluria. Role of the renin–angiotensin system. Urol Res 33:358PubMedCrossRef
137.
go back to reference Jonassen JA, Cao LC, Honeyman T et al (2003) Mechanisms mediating oxalate-induced alterations in renal cell functions. Crit Rev Eukaryot Gene Expr 13:55PubMedCrossRef Jonassen JA, Cao LC, Honeyman T et al (2003) Mechanisms mediating oxalate-induced alterations in renal cell functions. Crit Rev Eukaryot Gene Expr 13:55PubMedCrossRef
138.
go back to reference Umekawa T, Chegini N, Khan SR (2002) Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney Int 61:105PubMedCrossRef Umekawa T, Chegini N, Khan SR (2002) Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney Int 61:105PubMedCrossRef
139.
go back to reference Umekawa T, Iguchi M, Uemura H et al (2006) Oxalate ions and calcium oxalate crystal-induced up-regulation of osteopontin and monocyte chemoattractant protein-1 in renal fibroblasts. BJU Int 98:656PubMedCrossRef Umekawa T, Iguchi M, Uemura H et al (2006) Oxalate ions and calcium oxalate crystal-induced up-regulation of osteopontin and monocyte chemoattractant protein-1 in renal fibroblasts. BJU Int 98:656PubMedCrossRef
140.
go back to reference Iida S, Peck AB, Byer KJ et al (1999) Expression of bikunin mRNA in renal epithelial cells after oxalate exposure. J Urol 162:1480PubMedCrossRef Iida S, Peck AB, Byer KJ et al (1999) Expression of bikunin mRNA in renal epithelial cells after oxalate exposure. J Urol 162:1480PubMedCrossRef
141.
go back to reference Iida S, Peck AB, Johnson-Tardieu J et al (1999) Temporal changes in mRNA expression for bikunin in the kidneys of rats during calcium oxalate nephrolithiasis. J Am Soc Nephrol 10:986PubMed Iida S, Peck AB, Johnson-Tardieu J et al (1999) Temporal changes in mRNA expression for bikunin in the kidneys of rats during calcium oxalate nephrolithiasis. J Am Soc Nephrol 10:986PubMed
142.
go back to reference Grewal JS, Tsai JY, Khan SR (2005) Oxalate-inducible AMBP gene and its regulatory mechanism in renal tubular epithelial cells. Biochem J 387:609PubMedCrossRef Grewal JS, Tsai JY, Khan SR (2005) Oxalate-inducible AMBP gene and its regulatory mechanism in renal tubular epithelial cells. Biochem J 387:609PubMedCrossRef
143.
go back to reference Moriyama MT, Glenton PA, Khan SR (2001) Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats. J Urol 165:1687PubMedCrossRef Moriyama MT, Glenton PA, Khan SR (2001) Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats. J Urol 165:1687PubMedCrossRef
144.
go back to reference Suzuki K, Tanaka T, Miyazawa K et al (1999) Gene expression of prothrombin in human and rat kidneys: basic and clinical approach. J Am Soc Nephrol 10(Suppl 14):S408PubMed Suzuki K, Tanaka T, Miyazawa K et al (1999) Gene expression of prothrombin in human and rat kidneys: basic and clinical approach. J Am Soc Nephrol 10(Suppl 14):S408PubMed
145.
go back to reference Lieske JC, Spargo BH, Toback FG (1992) Endocytosis of calcium oxalate crystals and proliferation of renal tubular epithelial cells in a patient with type 1 primary hyperoxaluria. J Urol 148:1517PubMed Lieske JC, Spargo BH, Toback FG (1992) Endocytosis of calcium oxalate crystals and proliferation of renal tubular epithelial cells in a patient with type 1 primary hyperoxaluria. J Urol 148:1517PubMed
146.
go back to reference Mandell I, Krauss E, Millan JC (1980) Oxalate-induced acute renal failure in Crohn’s disease. Am J Med 69:628PubMedCrossRef Mandell I, Krauss E, Millan JC (1980) Oxalate-induced acute renal failure in Crohn’s disease. Am J Med 69:628PubMedCrossRef
147.
go back to reference Wharton R, D’Agati V, Magun AM et al (1990) Acute deterioration of renal function associated with enteric hyperoxaluria. Clin Nephrol 34:116PubMed Wharton R, D’Agati V, Magun AM et al (1990) Acute deterioration of renal function associated with enteric hyperoxaluria. Clin Nephrol 34:116PubMed
148.
go back to reference Whitworth JA (2003) 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21:1983PubMedCrossRef Whitworth JA (2003) 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21:1983PubMedCrossRef
149.
go back to reference Moritz AR, Oldt MR (1937) Arteriolar sclerosis in hypertensive and non-hypertensive individuals. Am J Pathol 13:679PubMed Moritz AR, Oldt MR (1937) Arteriolar sclerosis in hypertensive and non-hypertensive individuals. Am J Pathol 13:679PubMed
150.
go back to reference Kimmelstiel P, Wilson C (1936) Benign and malignant hypertension and nephrosclerosis: a clinical and pathological study. Am J Pathol 12:45PubMed Kimmelstiel P, Wilson C (1936) Benign and malignant hypertension and nephrosclerosis: a clinical and pathological study. Am J Pathol 12:45PubMed
151.
go back to reference Johnson RJ, Feig DI, Nakagawa T et al (2008) Pathogenesis of essential hypertension: historical paradigms and modern insights. J Hypertens 26:381PubMedCrossRef Johnson RJ, Feig DI, Nakagawa T et al (2008) Pathogenesis of essential hypertension: historical paradigms and modern insights. J Hypertens 26:381PubMedCrossRef
152.
go back to reference Montecucco F, Pende A, Quercioli A et al (2010) Inflammation in the pathophysiology of essential hypertension. J Nephrol 24:23CrossRef Montecucco F, Pende A, Quercioli A et al (2010) Inflammation in the pathophysiology of essential hypertension. J Nephrol 24:23CrossRef
153.
go back to reference Rodriguez-Iturbe B, Franco M, Tapia E et al (2011) Renal inflammation, autoimmunity and salt-sensitive hypertension. Clin Exp Pharmacol Physiol [Epub ahead of print] Rodriguez-Iturbe B, Franco M, Tapia E et al (2011) Renal inflammation, autoimmunity and salt-sensitive hypertension. Clin Exp Pharmacol Physiol [Epub ahead of print]
154.
go back to reference Rodriguez-Iturbe B, Vaziri ND, Johnson RJ (2008) Inflammation, angiotensin II, and hypertension. Hypertension 52:e135 (author reply e136) Rodriguez-Iturbe B, Vaziri ND, Johnson RJ (2008) Inflammation, angiotensin II, and hypertension. Hypertension 52:e135 (author reply e136)
155.
go back to reference Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J et al (2004) Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol 286:F606PubMedCrossRef Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J et al (2004) Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol 286:F606PubMedCrossRef
156.
go back to reference Stefanadi E, Tousoulis D, Androulakis ES et al (2010) Inflammatory markers in essential hypertension: potential clinical implications. Curr Vasc Pharmacol 8:509PubMedCrossRef Stefanadi E, Tousoulis D, Androulakis ES et al (2010) Inflammatory markers in essential hypertension: potential clinical implications. Curr Vasc Pharmacol 8:509PubMedCrossRef
157.
go back to reference Briones AM, Touyz RM (2010) Oxidative stress and hypertension: current concepts. Curr Hypertens Rep 12:135PubMedCrossRef Briones AM, Touyz RM (2010) Oxidative stress and hypertension: current concepts. Curr Hypertens Rep 12:135PubMedCrossRef
158.
go back to reference Nistala R, Whaley-Connell A, Sowers JR (2008) Redox control of renal function and hypertension. Antioxid Redox Signal 10:2047PubMedCrossRef Nistala R, Whaley-Connell A, Sowers JR (2008) Redox control of renal function and hypertension. Antioxid Redox Signal 10:2047PubMedCrossRef
159.
go back to reference Bautista LE, Lopez-Jaramillo P, Vera LM et al (2001) Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 19:857PubMedCrossRef Bautista LE, Lopez-Jaramillo P, Vera LM et al (2001) Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 19:857PubMedCrossRef
160.
go back to reference Chrysohoou C, Panagiotakos DB, Pitsavos C et al (2004) Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study. J Am Coll Cardiol 44:152PubMedCrossRef Chrysohoou C, Panagiotakos DB, Pitsavos C et al (2004) Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study. J Am Coll Cardiol 44:152PubMedCrossRef
161.
go back to reference Sesso HD, Buring JE, Rifai N et al (2003) C-reactive protein and the risk of developing hypertension. JAMA 290:2945PubMedCrossRef Sesso HD, Buring JE, Rifai N et al (2003) C-reactive protein and the risk of developing hypertension. JAMA 290:2945PubMedCrossRef
162.
go back to reference Kurata M, Okura T, Watanabe S et al (2006) Osteopontin and carotid atherosclerosis in patients with essential hypertension. Clin Sci (Lond) 111:319CrossRef Kurata M, Okura T, Watanabe S et al (2006) Osteopontin and carotid atherosclerosis in patients with essential hypertension. Clin Sci (Lond) 111:319CrossRef
163.
go back to reference Stumpf C, John S, Jukic J et al (2005) Enhanced levels of platelet P-selectin and circulating cytokines in young patients with mild arterial hypertension. J Hypertens 23:995PubMedCrossRef Stumpf C, John S, Jukic J et al (2005) Enhanced levels of platelet P-selectin and circulating cytokines in young patients with mild arterial hypertension. J Hypertens 23:995PubMedCrossRef
164.
go back to reference Wilcox CS (2002) Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep 4:160PubMedCrossRef Wilcox CS (2002) Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep 4:160PubMedCrossRef
165.
go back to reference O’Connor PM, Cowley AW Jr (2010) Modulation of pressure-natriuresis by renal medullary reactive oxygen species and nitric oxide. Curr Hypertens Rep 12:86PubMedCrossRef O’Connor PM, Cowley AW Jr (2010) Modulation of pressure-natriuresis by renal medullary reactive oxygen species and nitric oxide. Curr Hypertens Rep 12:86PubMedCrossRef
166.
go back to reference Ignarro LJ, Napoli C, Loscalzo J (2002) Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res 90:21PubMedCrossRef Ignarro LJ, Napoli C, Loscalzo J (2002) Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res 90:21PubMedCrossRef
167.
go back to reference Armas-Padilla MC, Armas-Hernandez MJ, Sosa-Canache B et al (2007) Nitric oxide and malondialdehyde in human hypertension. Am J Ther 14:172PubMedCrossRef Armas-Padilla MC, Armas-Hernandez MJ, Sosa-Canache B et al (2007) Nitric oxide and malondialdehyde in human hypertension. Am J Ther 14:172PubMedCrossRef
168.
go back to reference Rodriguez-Iturbe B, Romero F, Johnson RJ (2007) Pathophysiological mechanisms of salt-dependent hypertension. Am J Kidney Dis 50:655PubMedCrossRef Rodriguez-Iturbe B, Romero F, Johnson RJ (2007) Pathophysiological mechanisms of salt-dependent hypertension. Am J Kidney Dis 50:655PubMedCrossRef
169.
go back to reference Chabrashvili T, Tojo A, Onozato ML et al (2002) Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39:269PubMedCrossRef Chabrashvili T, Tojo A, Onozato ML et al (2002) Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39:269PubMedCrossRef
170.
go back to reference Schnackenberg CG, Welch WJ, Wilcox CS (1998) Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 32:59PubMed Schnackenberg CG, Welch WJ, Wilcox CS (1998) Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 32:59PubMed
171.
go back to reference Zalba G, Beaumont FJ, San Jose G et al (2000) Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 35:1055PubMed Zalba G, Beaumont FJ, San Jose G et al (2000) Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 35:1055PubMed
172.
go back to reference Grote K, Ortmann M, Salguero G et al (2006) Critical role for p47phox in renin–angiotensin system activation and blood pressure regulation. Cardiovasc Res 71:596PubMedCrossRef Grote K, Ortmann M, Salguero G et al (2006) Critical role for p47phox in renin–angiotensin system activation and blood pressure regulation. Cardiovasc Res 71:596PubMedCrossRef
173.
go back to reference Landmesser U, Cai H, Dikalov S et al (2002) Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40:511PubMedCrossRef Landmesser U, Cai H, Dikalov S et al (2002) Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40:511PubMedCrossRef
174.
go back to reference Zhou MS, Hernandez Schulman I, Pagano PJ et al (2006) Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure. Hypertension 47:81PubMedCrossRef Zhou MS, Hernandez Schulman I, Pagano PJ et al (2006) Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure. Hypertension 47:81PubMedCrossRef
175.
go back to reference Tian N, Moore RS, Phillips WE et al (2008) NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 295:R1858PubMedCrossRef Tian N, Moore RS, Phillips WE et al (2008) NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 295:R1858PubMedCrossRef
176.
go back to reference Taylor NE, Glocka P, Liang M et al (2006) NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt-sensitive hypertension in Dahl S rats. Hypertension 47:692PubMedCrossRef Taylor NE, Glocka P, Liang M et al (2006) NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt-sensitive hypertension in Dahl S rats. Hypertension 47:692PubMedCrossRef
177.
go back to reference Kanwar YS, Sun L, Xie P et al (2011) A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol 6:395PubMedCrossRef Kanwar YS, Sun L, Xie P et al (2011) A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol 6:395PubMedCrossRef
178.
go back to reference Navarro-Gonzalez JF, Mora-Fernandez C, Muros de Fuentes M et al (2011) Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol 7:327PubMedCrossRef Navarro-Gonzalez JF, Mora-Fernandez C, Muros de Fuentes M et al (2011) Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol 7:327PubMedCrossRef
179.
go back to reference Steckelings UM, Rompe F, Kaschina E et al (2009) The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets. Fundam Clin Pharmacol 23:693PubMedCrossRef Steckelings UM, Rompe F, Kaschina E et al (2009) The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets. Fundam Clin Pharmacol 23:693PubMedCrossRef
180.
go back to reference Matheson A, Willcox MD, Flanagan J et al (2010) Urinary biomarkers involved in type 2 diabetes: a review. Diabetes Metab Res Rev 26:150PubMedCrossRef Matheson A, Willcox MD, Flanagan J et al (2010) Urinary biomarkers involved in type 2 diabetes: a review. Diabetes Metab Res Rev 26:150PubMedCrossRef
181.
go back to reference Okonogi H, Nishimura M, Utsunomiya Y et al (2001) Urinary type IV collagen excretion reflects renal morphological alterations and type IV collagen expression in patients with type 2 diabetes mellitus. Clin Nephrol 55:357PubMed Okonogi H, Nishimura M, Utsunomiya Y et al (2001) Urinary type IV collagen excretion reflects renal morphological alterations and type IV collagen expression in patients with type 2 diabetes mellitus. Clin Nephrol 55:357PubMed
182.
183.
go back to reference Kakehi T, Yabe-Nishimura C (2008) NOX enzymes and diabetic complications. Semin Immunopathol 30:301PubMedCrossRef Kakehi T, Yabe-Nishimura C (2008) NOX enzymes and diabetic complications. Semin Immunopathol 30:301PubMedCrossRef
184.
go back to reference Chung SS, Ho EC, Lam KS et al (2003) Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 14:S233PubMedCrossRef Chung SS, Ho EC, Lam KS et al (2003) Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 14:S233PubMedCrossRef
185.
go back to reference Asaba K, Tojo A, Onozato ML et al (2005) Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int 67:1890PubMedCrossRef Asaba K, Tojo A, Onozato ML et al (2005) Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int 67:1890PubMedCrossRef
186.
go back to reference Etoh T, Inoguchi T, Kakimoto M et al (2003) Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibility by interventive insulin treatment. Diabetologia 46:1428PubMedCrossRef Etoh T, Inoguchi T, Kakimoto M et al (2003) Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibility by interventive insulin treatment. Diabetologia 46:1428PubMedCrossRef
187.
go back to reference Manea A (2010) NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology. Cell Tissue Res 342:325PubMedCrossRef Manea A (2010) NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology. Cell Tissue Res 342:325PubMedCrossRef
188.
go back to reference Brown BG, Zhao XQ, Chait A et al (2001) Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345:1583PubMedCrossRef Brown BG, Zhao XQ, Chait A et al (2001) Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345:1583PubMedCrossRef
189.
go back to reference Touyz RM (2003) Reactive oxygen species in vascular biology: role in arterial hypertension. Expert Rev Cardiovasc Ther 1:91PubMedCrossRef Touyz RM (2003) Reactive oxygen species in vascular biology: role in arterial hypertension. Expert Rev Cardiovasc Ther 1:91PubMedCrossRef
190.
go back to reference Manea A, Manea SA, Gafencu AV et al (2007) Regulation of NADPH oxidase subunit p22(phox) by NF-κB in human aortic smooth muscle cells. Arch Physiol Biochem 113:163PubMedCrossRef Manea A, Manea SA, Gafencu AV et al (2007) Regulation of NADPH oxidase subunit p22(phox) by NF-κB in human aortic smooth muscle cells. Arch Physiol Biochem 113:163PubMedCrossRef
191.
go back to reference Stefanadi E, Tousoulis D, Papageorgiou N et al (2010) Inflammatory biomarkers predicting events in atherosclerosis. Curr Med Chem 17:1690PubMedCrossRef Stefanadi E, Tousoulis D, Papageorgiou N et al (2010) Inflammatory biomarkers predicting events in atherosclerosis. Curr Med Chem 17:1690PubMedCrossRef
192.
go back to reference De Rosa S, Cirillo P, Paglia A et al (2010) Reactive oxygen species and antioxidants in the pathophysiology of cardiovascular disease: does the actual knowledge justify a clinical approach? Curr Vasc Pharmacol 8:259PubMedCrossRef De Rosa S, Cirillo P, Paglia A et al (2010) Reactive oxygen species and antioxidants in the pathophysiology of cardiovascular disease: does the actual knowledge justify a clinical approach? Curr Vasc Pharmacol 8:259PubMedCrossRef
193.
go back to reference Rivera J, Sobey CG, Walduck AK et al (2010) Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models. Redox Rep 15:50PubMedCrossRef Rivera J, Sobey CG, Walduck AK et al (2010) Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models. Redox Rep 15:50PubMedCrossRef
194.
go back to reference Drummond GR, Selemidis S, Griendling KK et al (2011) Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 10:453PubMedCrossRef Drummond GR, Selemidis S, Griendling KK et al (2011) Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 10:453PubMedCrossRef
195.
go back to reference Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87PubMedCrossRef Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87PubMedCrossRef
196.
go back to reference Kern PA, Ranganathan S, Li C et al (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280:E745PubMed Kern PA, Ranganathan S, Li C et al (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280:E745PubMed
197.
go back to reference Pradhan AD, Manson JE, Rifai N et al (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327PubMedCrossRef Pradhan AD, Manson JE, Rifai N et al (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327PubMedCrossRef
198.
go back to reference Furukawa S, Fujita T, Shimabukuro M et al (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114:1752PubMed Furukawa S, Fujita T, Shimabukuro M et al (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114:1752PubMed
199.
go back to reference Soares AF, Guichardant M, Cozzone D et al (2005) Effects of oxidative stress on adiponectin secretion and lactate production in 3T3–L1 adipocytes. Free Radic Biol Med 38:882PubMedCrossRef Soares AF, Guichardant M, Cozzone D et al (2005) Effects of oxidative stress on adiponectin secretion and lactate production in 3T3–L1 adipocytes. Free Radic Biol Med 38:882PubMedCrossRef
200.
go back to reference Silver AE, Beske SD, Christou DD et al (2007) Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47(phox) expression and evidence of endothelial oxidative stress. Circulation 115:627PubMedCrossRef Silver AE, Beske SD, Christou DD et al (2007) Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47(phox) expression and evidence of endothelial oxidative stress. Circulation 115:627PubMedCrossRef
201.
go back to reference Otani H (2011) Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxid Redox Signal 15:1911PubMedCrossRef Otani H (2011) Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxid Redox Signal 15:1911PubMedCrossRef
Metadata
Title
Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?
Publication date
01-04-2012
Published in
Urolithiasis / Issue 2/2012
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-011-0448-9

Other articles of this Issue 2/2012

Urolithiasis 2/2012 Go to the issue